Photochromic Blockers of Voltage-Gated Potassium Channels

Light work: Studies into the mechanism of AAQ, a photoswitchable blocker of voltage‐gated K+ channels, led to the discovery and development of photochromic ligands that act at the internal tetraethylammonium binding site (see picture). These molecules can be applied from the extracellular side to im...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie (International ed.) Vol. 48; no. 48; pp. 9097 - 9101
Main Authors Banghart, Matthew R, Mourot, Alexandre, Fortin, Doris L, Yao, Jennifer Z, Kramer, Richard H, Trauner, Dirk
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 01.01.2009
WILEY-VCH Verlag
WILEY‐VCH Verlag
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Light work: Studies into the mechanism of AAQ, a photoswitchable blocker of voltage‐gated K+ channels, led to the discovery and development of photochromic ligands that act at the internal tetraethylammonium binding site (see picture). These molecules can be applied from the extracellular side to impart long‐lasting photosensitivity on K+ channels in living cells and thereby afford photocontrol of action potential firing in neurons.
Bibliography:http://dx.doi.org/10.1002/anie.200904504
ark:/67375/WNG-2F9BMR50-7
This work was supported by a Laboratory Directed Research Development Award from the Lawrence Berkeley National Laboratory (R.H.K.), NSF-DFG grant CHE0724214 (D.T.), the National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241; R.H.K. and D.T.), and by a grant from the Human Frontier Science Program (RGP23-2005; R.H.K. and D.T.). We thank F. Tombola and E. Isacoff for insightful discussions, the Isacoff and Yellen laboratories for Shaker clones, and T. Fehrentz for additional experiments (not included).
Lawrence Berkeley National Laboratory
National Institutes of Health - No. 5PN2EY018241
NSF-DFG - No. CHE0724214
istex:3A28FC4AEFB2B3EE9254A97FF9E56BB1D9445FCF
Human Frontier Science Program - No. RGP23-2005
ArticleID:ANIE200904504
These authors contributed equally to this work.
This work was supported by a Laboratory Directed Research Development Award from the Lawrence Berkeley National Laboratory (R.H.K.), NSF‐DFG grant CHE0724214 (D.T.), the National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241; R.H.K. and D.T.), and by a grant from the Human Frontier Science Program (RGP23‐2005; R.H.K. and D.T.). We thank F. Tombola and E. Isacoff for insightful discussions, the Isacoff and Yellen laboratories for Shaker clones, and T. Fehrentz for additional experiments (not included).
NIH RePORTER
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.200904504